Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding IT:SELJLB?
Track your performance easily
IT:SELJLB Price & Analysis
SELJLB ETF Chart & Stats
Day’s Range― - ―
52-Week Range€104.25 - €131.01
Previous Close€104.49
VolumeN/A
Average Volume (3M)N/A
AUM375.62K
NAV104.49
Expense Ratio3.36%
Holdings Count28
Beta0.37
Inception DateJan 24, 2011
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares OutstandingN/A
Standard Deviation0.00
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Alpha0.00
Selectra Investments SICAV - J. Lamarck Biotech (SELJLB) Fund Flow Chart
Selectra Investments SICAV - J. Lamarck Biotech (SELJLB) 1 year Net Flows: -€33K
SELJLB ETF News
SELJLB ETF FAQ
What was IT:SELJLB’s price range in the past 12 months?
IT:SELJLB lowest ETF price was €104.25 and its highest was €131.01 in the past 12 months.
What is the AUM of IT:SELJLB?
As of Nov 19, 2024 The AUM of IT:SELJLB is 375.62K.
Is IT:SELJLB overvalued?
According to Wall Street analysts IT:SELJLB’s price is currently Undervalued.
Does IT:SELJLB pay dividends?
IT:SELJLB does not currently pay dividends.
How many shares outstanding does IT:SELJLB have?
Currently, no data Available
Which hedge fund is a major shareholder of IT:SELJLB?
Currently, no hedge funds are holding shares in IT:SELJLB
SELJLB ETF Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Exelixis
10.22%
Gilead Sciences
8.88%
Biogen Inc.
7.77%
Ionis Pharmaceuticals Inc.
6.22%
Incyte
5.40%
Denali Therapeutics
5.11%
Amgen Inc
4.59%
Alnylam Pharmaceuticals
4.45%
Alkermes plc
4.43%
Vertex Pharmaceuticals Inc.
4.32%
Total61.38%
ETF Description
Selectra Investments SICAV - J. Lamarck Biotech
The main objective of this Sub-Fund is to profit from increasing share prices in the biotechnology sector. The focus is on mature top tier pharmaceutical biotech companies and companies with interesting pipeline of products in development in a single or numerous markets, like Nasdaq or NYSE.